Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[18F]fluoro-L-dopa PET study

Brain

Volumn 125, Issue 6, 2002, Pages 1358-1365

  Ito, Kengo ^a   Nagano Saito, Atsuko ^a   Kato, Takashi ^a   Arahata, Yutaka ^a   Nakamura, Akinori ^a   Kawasumi, Yasuhiro ^a   Hatano, Kentaro ^a   Abe, Yuji ^b   Yamada, Takako ^b   Kachi, Teruhiko ^b   Brooks, David J ^c,d  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b CHUBU NATIONAL HOSPITAL   (Japan)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

6 18F fluoro L dopa; Parkinson's disease; Parkinson's disease with dementia; Positron emission tomography

Indexed keywords

6 FLUORODOPA F 18;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEMENTIA; EQUIPMENT; FEMALE; HUMAN; MALE; MESENCEPHALON; MESOLIMBIC DOPAMINERGIC SYSTEM; PARAMETRIC TEST; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RATING SCALE;

EID: 0036260184     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf134     Document Type: Article

References (40)

1. Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study
2. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: A positron emission tomographic study
3. Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow
4. Parkinson disease, dementia, and Alzheimer disease: Clinicopathological correlations
5. Nigral and extranigral pathology in Parkinson's disease
6. Detection of preclinical Parkinson's disease with PET
7. How common is dementia in Parkinson's disease?
8. 18F-dopa and positron emission tomography
9. Comparing functional (PET) images: The assessment of significant change
10. A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum
11. Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases
12. Dementia in Parkinson disease: A neuropathologic study
13. Functional effects of striatal dysfunction in Parkinson disease
14. Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease
15. Dementia and neuropathology in Lewy body disease
16. Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease?
17. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
18. Dementia in Parkinson disease
19. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease
20. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
21. Dementia with Lewy bodies: Reliability and validity of clinical and pathologic criteria
22. Clinical and [18F] dopa PET findings in early Parkinson's disease
23. Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain - An approach using MRI-aided spatial normalization
24. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for beta-CFT binding with positron emission tomography
25. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations
26. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data
27. Abnormal, ubiquitinated cortical neurites in patients with diffuse Lewy body disease
28. Senile dementia of Lewy body type
29. 18F]dopa-PET study
30. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra
31. 18F]fluorodopa positron emission tomographic study
32. 18F-dopa positron emission tomography studies in an Irish kindred
33. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease
34. Aromatic L-amino-acid decarboxylase (DOPA decarboxylase) gene expression in dopaminergic and serotoninergic cells of the rat brainstem
35. The association of ventral tegmental area histopathology with adult dementia
36. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity
37. Basal forebrain neurons in the dementia of Parkinson disease
38. Rapid automated algorithm for aligning and reslicing PET images
39. MRI-PET registration with automated algorithm